Filter
190
Filtered Results: 190
Text search:
Bedaquiline
Featured
Recommendations
34
New Publications
54
Language
Document type
No document type
121
Guidelines
25
Studies & Reports
20
Manuals
10
Fact sheets
5
Training Material
3
Situation Updates
3
Strategic & Response Plan
3
Countries / Regions
Western and Central Europe
20
Eastern Europe
16
India
12
Germany
4
Asia
3
South Africa
3
Uganda
3
Ethiopia
3
El Salvador
2
Latin America and the Carribbean
2
South–East Asia Region
2
Eastern Europe and Central Asia
2
Bolivia
2
Argentina
2
Russia
2
Nepal
1
Kenya
1
Ukraine
1
Nigeria
1
Estonia
1
Malawi
1
Philippines
1
Global
1
Dominican Republic
1
Paraguay
1
Bangladesh
1
Brazil
1
Namibia
1
Romania
1
Georgia
1
Botswana
1
Zambia
1
Authors & Publishers
Publication Years
Category
TB
35
Policies & Guidelines HIV & TB
32
Drugs & Medical Equipment
6
Statistics
5
Pediatrics
3
Studies & Reports
3
Bacteriology
2
Disease Prevention & Control
2
Communicable Diseases
1
Buruli Ulcer
1
COVID-19
1
x MEDBOX Issue Brief & Annual Reports x
1
Palliative Care
1
Countries
1
Policies
1
Guidelines
1
Capacity Building
1
Palliative Care
1
General Guidelines
1
Toolboxes
Drug resistant TB
37
Adults
18
Detection & Diagnosis
18
Prevention & Control
16
Children
13
Reports
10
Eastern Europe & Central Asia
10
Research & Access
7
Policies & Strategies
6
Childhood TB
6
Training
6
General
5
Other Countries
4
Disease Prevention & Control
4
Germany
4
SEAR (South-east Asia Region)
4
Moldova
3
TB & Other Vulnerable Populations
3
Drug resistance
3
Essential Medicines
3
Essential Medicines & Devices Lists
3
HIV &TB
3
Co-Morbidities (except TB)
3
TB & Prisoners
3
Ukraine
2
TB
2
Georgia
2
Russia
2
Ethiopia
2
Studies
2
TB/COVID-19
2
Advocacy & Communication
2
Latin America
2
El Salvador
2
Prices and Patents
2
Argentina
2
Romania
2
Western & Central Europe
2
TB
2
Biosafety
1
Azerbaijan
1
Clinical Aspects, Treatment & Prevention
1
Clinical Aspects
1
Children & Adolescents
1
Prophylaxis
1
African Region
1
Country Guidelines
1
Belarus
1
Communication & Training
1
General
1
Research & Development
1
General
1
Country specific documents
1
Global Impact: Socio-economic, health services, TB & HIV
1
Latin America
1
Estonia
1
Rational use of Medicine
1
Health Care In Conflict Settings
1
Studies & Reports
1
Armenia
1
Policies and guidelines
1
Regional Reports & Guidelines, others
1
Human Rights & the Right to Health
1
TB/HIV Global
1
Latin America & the Carribean
1
Assessment
1
TB/HIV Coinfection
1
Kazakhstan
1
AmR (Region of Americas)
1
Antiretroviral Treatment ART
1
Kenya
1
AMR
1
Interim policy guidance
Int. J. Mol. Sci. 2017, 18, 341, 1 - 10
The new, all oral, 20-month MDR-TB regimens range from US $1,600* (using bedaquiline and linezolid for 6 months and levofloxacin as the fluoroquinolone) to US $2,100* (using linezolid for 12 months and moxifloxacin as the fluoroquinolone.
A large meta-analysis of observational studies that provided the basis for the recent makeover of global recommendations for multidrug-resistant tuberculosis (MDR-TB) treatment shows that newer and repurposed drugs produced better outcomes and fewer deaths than older treatments.
The meta-analysis...
For the first time in almost 50 years there are two new drugs for the treatment of drug-resistant TB (DR-TB): bedaquiline and delamanid. There has also been increased attention given to the safety and efficacy of “re-purposed” drugs that have been widely used to treat other infections but are al...
A review of available evidence (2016).
28-29 June 2016; Geneva, Switzerland
The END TB strategy.
The use of Delamanid and Bedaquiline for Children with Drug-Resistant Tuberculosis.
MMWR: Recommendations and Reports / Vol. 62 / No. 9
Morbidity and Mortality Weekly Report
October 25, 2013
12 countries have a high TB estimated burden with an incidence rate more than 45 per 100 000 population They represent 88 of the cases in the Region
In 2019 the TB case detection gap in the Region was 52 500 cases
The Updated guidelines on Management of tuberculosis in children and adolescents include new recommendations that cover diagnostic approaches for TB, shorter treatment for children with non-severe drug-susceptible TB, a new option for the treatment of TB meningitis, the use of bedaquiline and delama...
